CARRIER PROTEIN-MONENSIN CONJUGATES - ENHANCEMENT OF IMMUNOTOXIN CYTOTOXICITY AND POTENTIAL IN TUMOR TREATMENT

被引：0
|
作者：
COLOMBATTI, M
DELLARCIPRETE, L
CHIGNOLA, R
TRIDENTE, G
机构：
来源：
CANCER RESEARCH | 1990年 / 50卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1385 / 1391
页数：7
相关论文
共 25 条
  • [1] BLOCKING EFFECT OF HUMAN SERUM BUT NOT OF CEREBROSPINAL-FLUID ON RICIN-A CHAIN IMMUNOTOXIN POTENTIATION BY MONENSIN OR CARRIER PROTEIN-MONENSIN CONJUGATES
    CANDIANI, C
    FRANCESCHI, A
    CHIGNOLA, R
    PASTI, M
    ANSELMI, C
    BENONI, G
    TRIDENTE, G
    COLOMBATTI, M
    CANCER RESEARCH, 1992, 52 (03) : 623 - 630
  • [2] MECHANISMS INVOLVED IN SERUM-DEPENDENT INACTIVATION OF THE IMMUNOTOXIN ENHANCERS MONENSIN AND CARRIER-PROTEIN-MONENSIN
    FRANCESCHI, A
    DOSIO, F
    ANSELMI, C
    CHIGNOLA, R
    CANDIANI, C
    PASTI, M
    TRIDENTE, G
    COLOMBATTI, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 219 (1-2): : 469 - 479
  • [3] ENHANCEMENT OF THE SPECIFIC CYTOTOXICITY OF A BREAST CANCER-ASSOCIATED ANTIGEN IMMUNOTOXIN BY THE CARBOXYLIC IONOPHORE MONENSIN
    GRIFFIN, TW
    PAGNINI, PG
    HOUSTON, LL
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1987, 6 (05): : 537 - 545
  • [4] GOLGI VACUOLIZATION AND IMMUNOTOXIN ENHANCEMENT BY MONENSIN AND PERHEXILINE DEPEND ON A SERUM-PROTEIN - IMPLICATIONS FOR INTRACELLULAR TRAFFICKING
    JANSEN, FK
    JANSEN, A
    DEROCQ, JM
    CARRIERE, D
    CARAYON, P
    VEAS, F
    JAFFREZOU, JP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (18) : 12577 - 12582
  • [5] EFFECT OF HAPTEN VALENCY AND CARRIER COMPOSITION ON THE TOLEROGENIC POTENTIAL OF HAPTEN-PROTEIN CONJUGATES
    PIKE, BE
    BATTYE, FL
    NOSSAL, GJV
    JOURNAL OF IMMUNOLOGY, 1981, 126 (01): : 89 - 94
  • [6] Protein-nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia
    Maximov, V. D.
    Reukov, V. V.
    Barry, J. N.
    Cochrane, C.
    Vertegel, A. A.
    NANOTECHNOLOGY, 2010, 21 (26)
  • [7] Size and zeta potential analysis of synthetic peptide-carrier protein conjugates depend on the time
    Derman, Serap
    Dalgakiran, Eray
    Mustafaeva, Zeynep
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 162 - 162
  • [8] Novel immunotoxin:: A fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis
    Hossann, M
    Li, ZY
    Shi, YW
    Kreilinger, U
    Büttner, J
    Vogel, PD
    Yuan, JM
    Wise, JG
    Trommer, WE
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 46 (01) : 73 - 84
  • [9] Novel immunotoxin:: A fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis.
    Hossann, M
    Li, Z
    Shi, Y
    Kreilinger, U
    Buettner, J
    Vogel, PD
    Jingming, Y
    Wise, JG
    Trommer, WE
    CLINICAL IMMUNOLOGY, 2005, 115 : S88 - S88
  • [10] Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas
    Betting, David J.
    Kafi, Kamran
    Abdollahi-Fard, Alireza
    Hurvitz, Sara A.
    Timmerman, John M.
    JOURNAL OF IMMUNOLOGY, 2008, 181 (06): : 4131 - 4140
123